Recombinant Human G-CSF (CSF3)

Catalog No : IGX-RP202
1458.43€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Recombinant Human G-CSF (CSF3)
Catalog No IGX-RP202
Supplier’s Catalog No IGX-RP202
Supplier ImuGeX
Source antigen CHO cells
Reactivity Human
Cross reactivity
Applications
Molecular weight 19
Storage -70°C
Other names GCSF, Pluripoietin, INN=Filgrastim, INN=Lenograstim, C17orf33, GCSF<br/>Recombinant Human Granulocyte Colony-Stimulating Factor (CSF3)
Grade Highly Purified
Purity >95% as determined by SDS-PAGE
Form Recombinant G-CSF was lyophilized from a 0.2 μm filtered PBS solution pH 7.0.
Reactivity life 6 months
Note For reserch purpose only
Purity >95% as determined by SDS-PAGE
Description G-CSF is secreted by monocytes, macrophages, and neutrophils after cell activation. It is produced also by stromal cells, fibroblasts, and endothelial cells. Epithelial carcinomas, acute myeloid leukemia cells and various tumor cell lines. The synthesis of G-CSF can be induced by bacterial endotoxins, TNF, IL-1 and GM-CSF. Comparison of the primary sequence of G-CSF with those of the two other colony stimulating factors, GM-CSF and M-CSF, shows that the three factors are not related to each other. Murine and human G-CSF show a sequence homology of approximately 70% at the DNA level and of 72% at the protein level. The G-CSF receptor, CD114, is expressed on all cells of the neutrophils and granulocytes lineage. It is expressed also in placenta cells, endothelial cells and various carcinoma cell lines. Human G-CSF is active in murine cells and vice versa. G-CSF stimulates the proliferation and differentiation of hematopoietic progenitor cells committed to the neutrophils and granulocytes lineage in a dose-dependent manner. G-CSF synergises with some other cytokines, including GM-CSF and IL-4. GM-CSF and G-CSF are required, for example, to develop neutrophilic colonies in vitro. The concerted action of G-CSF and Epo is required to support the growth of mixed colonies of the early erythroid progenitors. A combination of IL-4 with G-CSF has been shown to lead to synergistic suppression of the growth of some human leukemic cell lines.